Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Leahy
Michael Leahy
Peter MacCallum Cancer Centre
ABL
Cancer research
breakpoint cluster region
Biology
Medicine
4
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
domain mutations identify imatinib-treated patients with CML who have BCR-ABL kinase Real-time quantitative PCR analysis can be used as a primary screen to
2012
Robin Filshie
Ken Bradstock
Richard Herrmann
David Joske
Kevin Lynch
Timothy Hughes
Simon Durrant
Peter Browett
Anthony P. Schwarer
Christopher Arthur
John Catalano
Michael Leahy
Susan Branford
Zbigniew Rudzki
Ian H. Parkinson
Andrew Grigg
Kerry Taylor
John F Seymour
Show All
Source
Cite
Save
Citations (0)
Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy.
2011
Medical Physics
C Fox
Tomas Kron
Michael Leahy
Gillian Duchesne
Scott Williams
Keen Hun Tai
Annette Haworth
Alan Herschtal
Farshad Foroudi
Show All
Source
Cite
Save
Citations (3)
Repeat Treatment with Iodine-131-Rituximab Is Safe and Effective in Patients with Relapsed Indolent B-Cell Non-Hodgkin Lymphoma (NHL) Who Had Previously Responded to This Therapy.
2007
Blood
Mark J. Bishton
Michael Leahy
R. Hicks
J. Harvey Turner
Ad McQuillan
John F. Seymour
Show All
Source
Cite
Save
Citations (0)
Short Title: RQ -PCR identifies patients with BCR -ABL mutations
2004
Susan Branford
Zbigniew Rudzki
Ian H. Parkinson
Andrew P Grigg
K. Taylor
John F Seymour
Simon Durrant
Peter Browett
Anthony P. Schwarer
Christopher Arthur
John Catalano
Michael Leahy
Robin Filshie
Ken Bradstock
Richard Herrmann
David Joske
Kevin Lynch
Show All
Source
Cite
Save
Citations (0)
1